Dr. Steven Quay, MD, Ph.D. - CEO, Atossa Therapeutics - Novel Therapeutics For Preventing And Treating Breast Cancer

Dr. Steven Quay, MD, Ph.D. ( https://drquay.com/ ) is Chairman of the Board and Chief Executive Officer of Atossa Therapeutics ( https://atossatherapeutics.com/ ), a biopharmaceutical company developing novel therapeutics for the prevention and treatment of breast cancer.

Dr. Quay is certified in Anatomic Pathology with the American Board of Pathology, completed both an internship and residency in anatomic pathology at Massachusetts General Hospital, a Harvard Medical School teaching hospital, and is a former faculty member of the Department of Pathology, Stanford University School of Medicine.

Dr. Quay is a named inventor on 87 U.S. patents, 130 pending U.S. patent applications, and is named inventor on patents covering five pharmaceutical products that have been approved by the U.S. Food and Drug Administration. 

Dr. Quay received an MD and a Ph.D. from the University of Michigan. He received his B.A. degree in biology, chemistry and mathematics from Western Michigan University. 

#StevenQuay #AtossaTherapeutics #BreastCancer #SelectiveEstrogenReceptorModulators #AromataseInhibitors #SelectiveEstrogenReceptorDegraders #Tamoxifen #Zendoxifen #MetastaticDisease #MammographicBreastDensity #GlioblastomaMultiforme #DuchenneMuscularDystrophy #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast